Skip to main content
. 2017 Feb;8(1):89–95. doi: 10.21037/jgo.2016.12.03

Table 1. Clinical characteristics of patients with adenocarcinoma (ACA), adenosquamous carcinoma (ASC) and squamous cell carcinoma (SqCC).

Characteristic ACA (%) SqCC (%) ASC (%) Total (%) P value
Count 18,110 (60.6) 11,496 (38.5) 284 (1.0) 29,890 (100.0)
Age (years)/SEM 66.4/13.8 67.3/11.5 65.3/11.3 66.8/13.0
Gender <0.001
   Male 15,610 (86.2) 7,531 (65.5) 239 (84.2) 23,380 (78.2)
   Female 2,500 (13.8) 3,965 (34.5) 45 (15.8) 6,510 (21.8)
Race <0.001
   White 17,246 (95.2) 7,370 (64.1) 244 (85.9) 24,860 (83.2)
   Black 445 (2.5) 3,015 (26.2) 24 (8.5) 3,484 (11.7)
   Other 419 (2.3) 1,111 (9.7) 16 (5.6) 1,546 (5.2)
Grade <0.001
   I/II 7,112 (39.3) 4,850 (42.2) 44 (15.5) 12,006 (40.2)
   III/IV 8,107 (44.8) 4,591 (39.9) 207 (72.9) 12,905 (43.2)
   Unknown 2,891 (16.0) 2,055 (17.9) 33 (11.6) 4,979 (16.7)
SEER historic stage <0.001
   Localized 4,980 (27.5) 3,212 (27.9) 41 (14.4) 8,233 (27.5)
   Regional 5,823 (32.2) 4,323 (37.6) 106 (37.3) 10,252 (34.3)
   Distant 7,307 (40.3) 3,961 (34.5) 137 (48.2) 11,405 (38.2)
AJCC staging (2004+) <0.001
   I/IIa 3,665 (32.4) 2,152 (34.6) 32 (20.1) 5,849 (33.1)
   IIb–IVa 3,966 (35.1) 2,528 (40.7) 65 (40.9) 6,559 (37.1)
   IVb 3,669 (32.5) 1,535 (24.7) 62 (39.0) 5,266 (29.8)
Primary site <0.001
   Cervical/upper 253 (1.4) 1,999 (17.4) 12 (4.2) 2,264 (7.6)
   Thoracic/middle 1,459 (8.1) 4,590 (39.9) 60 (21.1) 6,109 (20.4)
   Abdominal/lower 14,451 (79.8) 3,292 (28.6) 177 (62.3) 17,920 (60.0)
   Esophagus, NOS 1,947 (10.8) 1,615 (14.0) 35 (12.3) 3,597 (12.0)
Surgery <0.001
   Resection 5,637 (31.1) 1,826 (15.9) 93 (32.7) 7,556 (25.3)
   No resection 12,473 (68.9) 9,670 (84.1) 191 (67.3) 22,334 (74.7)
LN examined <0.001
   No 12,123 (66.9) 9,237 (80.3) 191 (67.3) 21,551 (72.1)
   Yes 5,801 (32.0) 2,157 (18.8) 92 (32.4) 8,050 (26.9)
Radiation <0.001
   No 8,502 (46.9) 4,125 (35.9) 128 (45.1) 12,755 (42.7)
   Yes 9,608 (53.1) 7,371 (64.1) 156 (54.9) 17,135 (57.3)

SEM, standard error of mean; NOS, not otherwise specified; LN, lymph nodes.